Chickenpox: all 156 studies
Page 2 of 2. Open to participants first (26), then studies with results posted, then the rest; newest registration first within each.
- Comparison of Immunization Quality Improvement Dissemination StudyCompletedNCT02432430Not applicable
- Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic TherapyTerminatedNCT02408159Phase 4
- Dose-escalation Phase 1 to Evaluate the Safety and Efficacy of MG1111 in Healthy AdultsCompletedNCT02367638Phase 1
- VZV Vaccine for Hematopoietic Stem Cell TransplantationCompletedNCT02329457Phase 2/3
- Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella VaccineCompletedNCT02173899Phase 4
- Study on Effectiveness of 2-dose Live Attenuated Varicella VaccineStatus unknownNCT02146469Phase 4
- Persistence of Varicella Immunity in Hospital Employees Receiving Varicella VaccineWithdrawnNCT02026089Phase 4
- Immune Persistence After Inoculated With One-dose Freeze-Dried Live Attenuated Varicella Vaccine in Children Vaccine in ChildrenStatus unknownNCT01982409Phase 4
- iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and NeuroblastomaActive, not recruitingNCT01953900Phase 1
- Varicella-related Hospitalizations in TurkeyCompletedNCT01887496
- The Safety and Immunogenicity Research of Live Attenuated Varicella Vaccine After the 2 Doses VaccinationStatus unknownNCT01866566Phase 4
- The Safety, Immunogenicity and Immune Effect Research of the Varicella Vaccine After the 2nd Dose VaccinationStatus unknownNCT01830283Phase 4
- Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella VaccineCompletedNCT01817270Phase 4
- Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE VaccineCompletedNCT01815073Phase 4
- Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the PhilippinesWithdrawnNCT01738841
- Safety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without GelatinCompletedNCT01684072Phase 4
- A Study to Evaluate the Immunogenicity, Safety, and Tolerability of VARIVAX™ Manufactured With a New Process (V210-062)WithdrawnNCT01626794Phase 3
- ZOSTAVAX™ (Zoster Vaccine Live) Long-term Effectiveness Study (V211-024)CompletedNCT01600079
- Safety of Zostavax Vaccination in Rheumatoid ArthritisCompletedNCT01506661Phase 1
- Cytokine Production and Immunity to Varicella Zoster Virus (VZV) in Elderly Recipients of Zoster VaccineCompletedNCT01288014
- Vitamin D Supplementation And Varicella Zoster Virus Vaccine Responsiveness In Older Long-Term Care ResidentsCompletedNCT01262300Phase 1
- Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella PertussisCompletedNCT01160081
- The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected ChildrenCompletedNCT01138215Phase 4
- Serological Evaluation of Varicella and Hepatitis A Vaccines Using Injector DeliveryStatus unknownNCT00926419Phase 2/3
- Immune Response to Varicella-Zoster Vaccination and InfectionCompletedNCT00921999
- Safety of a Second Dose of Biken's Varicella VaccineCompletedNCT00830648Phase 4
- The Effectiveness of Varicella Vaccination in Children in GermanyCompletedNCT00679796
- Varicella Vaccination With PulmicortCompletedNCT00641446Phase 4
- Safety,Tolerability and Immunogenicity of Vaccination With VARIVAX in Healthy Indian Children (V210-056)CompletedNCT00496327Phase 3
- ZOSTAVAX(R) Local Registration Trial (V211-019)CompletedNCT00444860Phase 3
- Safety Study of a Refrigerator-stable Formulation of VARIVAX®CompletedNCT00432731Phase 4
- Immunogenicity and Safety of Concomitant Administration of MMR™ rHA and VARIVAX® by Intramuscular Versus Subcutaneous Route (V205C-011)CompletedNCT00432523Phase 3
- Efficacy of TCA Effect on Varicella Atrophic ScarsStatus unknownNCT00422539Phase 2
- Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined VaccineCompletedNCT00406211Phase 3
- Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™CompletedNCT00353288Phase 2
- Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™CompletedNCT00352898Phase 2
- Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration RoutesCompletedNCT00351923Phase 3
- Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella InfectionApproved for marketingNCT00338442
- Immune Responses to Two Dose Varivax +/- MMR-IITerminatedNCT00258726Phase 1/2
- The Safety of Oka Varicella in Children Prior to Solid Organ TransplantationCompletedNCT00213304Phase 3
- Evaluation Of Valaciclovir In Patients With ChickenpoxCompletedNCT00169416Phase 3
- MMR and Varicella Vaccine in Premature InfantsCompletedNCT00156559
- Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella VaccinesTerminatedNCT00138255
- Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00127023Phase 3
- Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00127010Phase 3
- Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00126997Phase 4
- Shingles: Immune Effects of Tai ChiCompletedNCT00118885Phase 2
- Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster InfectionCompletedNCT00098046Phase 3
- Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)CompletedNCT00092430Phase 3
- Tai Chi Chih and Varicella Zoster ImmunityCompletedNCT00029484Phase 2
- A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZVCompletedNCT00002358Phase 3
- A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune SystemsCompletedNCT00002315Phase 3
- Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had ChickenpoxCompletedNCT00001125Phase 1
- The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected ChildrenWithdrawnNCT00001054Phase 1
- Comparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected PatientsCompletedNCT00000953Phase 2
- A Study of the Safety and Effectiveness of a Chickenpox Vaccine in HIV-Infected ChildrenCompletedNCT00000837Phase 1